- 29 Jul 2017 Allan Bradley at Canaccord Genuity Growth Conference
- 9 Jan 2017 Kymab expands Infectious Disease Programmes
- 24 Nov 2016 Kymab secures US$100 million Series C funding
- 6 May 2015 Kymab secures US$90 million funding
- 16 May 2014 Gates and Wellcome Trust invest in Kymab
- 12 Jul 2010 Wellcome Trust £20 million financing agreement
We use cookies on our website. Carry on browsing if you’re happy with this or find out more
Featured article: Kymab presents two e-posters at the American Association for Cancer Research Virtual Annual Meeting
Cambridge, UK; 22 June 2020: Kymab, a clinical-stage biopharmaceutical company developing antibody-based therapeutics, today announced th...
Read article
Featured article: US Patent Trial and Appeal Board rejects fifth request by Regeneron for invalidation of Kymab's US patents
USPTO upholds a fifth Kymab patent covering Human Antibodies and Platforms
Read article